Artificial intelligence is changing the way people interact online, and the pace of innovation is accelerating. Just a few years ago, generative AI was a novelty. Today, platforms such as ChatGPT have become essential tools for millions, shaping how information is shared and decisions are made.
At EVERSANA INTOUCH, we’re closely monitoring the next phase of this transformation. The future of AI is not just about smarter conversations. It is about opening new channels for brands to reach their audiences. Imagine connecting with key stakeholders not only through traditional digital media, but also within the trusted AI experiences they use every day. For pharma marketers, this means greater visibility, deeper engagement and the opportunity to lead in a rapidly evolving space.
With new opportunities come new challenges. The rules for AI-powered advertising are still being written, and the timeline remains uncertain. What is clear is that marketers who prepare now will be ready to take advantage when the time comes. Our latest point of view explores the signals, strategies and steps pharma brands should consider, without revealing all the details.
Are you curious about what is next for AI-driven advertising? Do you want to know how your brand can be ready for the future before your competitors? Download our exclusive POV to discover the insights senior marketers need to stay ahead.
To access the full report and join the conversation about the next frontier in pharma marketing, provide your contact information below.
Access the POV
Submit Your Details to Access the Content